Astria Therapeutics, Inc. (ATXS) Misses Q3 EPS by 14c

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of ($0.63), $0.14 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c